PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges

October 10, 2018

Applied Clinical Trials

PAREXEL International Corporation, a provider of global biopharmaceutical services, announced that it has developed new solutions that take a patient-centric approach to addressing drug development. These solutions were built on the Perceptive Cloud platform in hopes to leverage mobile and wearable technology.

Read the full release here.  

Related Content:

News